REGENXBIO (RGNX) IPO Opens Up 38%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
REGENXBIO Inc. (Nasdaq: RGNX) to Ring The Nasdaq Stock Market Opening Bell
September 17, 2015 6:00 AM EDTADVISORY, Sept. 17, 2015 (GLOBE NEWSWIRE) --
What:Â
REGENXBIO Inc. (Nasdaq: RGNX), a leading biotechnology company in gene therapy, will visit the Nasdaq MarketSite in Times Square to celebrate its recent initial public offering (IPO).
In honor of the occasion, Ken Mills, President and Chief Executive Officer, will ring the Opening Bell.Â
Where:
Nasdaq MarketSite 4 Times Square 43rd & Broadway Broadcast Studio
When:
Thursday, September 17, 2015 9:15 a.m. to 9:30 a.m. ETÂ Â Â Â Â Â Â Â Â
REGENXBIO Inc. Media Contact:Laura Bagby, 6 Degrees PR(312)... More
REGENXBIO Announces Pricing of Initial Public Offering
September 16, 2015 8:30 PM EDTROCKVILLE, Md., Sept. 16, 2015 (GLOBE NEWSWIRE) -- REGENXBIO Inc. ("REGENXBIO"), a leading biotechnology company in gene therapy, today announced the pricing of its initial public offering of 6,300,000 shares of its common stock at a public offering price of $22.00 per share, before underwriting discounts and commissions. In addition, REGENXBIO granted the underwriters a 30-day option to purchase up to an additional 945,000 shares of its common stock at the same price. The shares are scheduled to begin trading on The NASDAQ Global Select Market on September 17, 2015 under the ticker symbol "RGNX."
Morgan Stanley and BofA Merrill Lynch are acting as active joint... More
